Ikonisys S.A. (EPA: ALIKO)

France flag France · Delayed Price · Currency is EUR
1.480
-0.010 (-0.67%)
Nov 19, 2024, 12:10 PM CET
5.71%
Market Cap 15.77M
Revenue (ttm) 471.50K
Net Income (ttm) -2.70M
Shares Out 11.26M
EPS (ttm) -0.26
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,311
Open 1.480
Previous Close 1.490
Day's Range 1.470 - 1.480
52-Week Range 1.230 - 1.800
Beta 0.66
Analysts n/a
Price Target n/a
Earnings Date Apr 29, 2025

About Ikonisys

Ikonisys S.A., a cell-based diagnostics company, develops, produces, and markets medical diagnostic products for early and accurate detection of cancer diseases in the United States and Europe. It offers Ikoniscope Robotic Microscopes, including Ikoniscope20 that provides automated slide handling, slide scanning, and real-time image capture and analysis; and Ikoniscope20max that automates the fluorescence microscopy solution. The company also provides oncoFISH bladder that allows scanning and analysis of cells from a voided urine sample; oncoFI... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2021
Employees 10
Stock Exchange Euronext Paris
Ticker Symbol ALIKO
Full Company Profile

Financial Performance

In 2023, Ikonisys's revenue was 448,557, a decrease of -27.28% compared to the previous year's 616,866. Losses were -2.27 million, -7.38% less than in 2022.

Financial Statements

News

There is no news available yet.